secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2022-11-22T23:59:59+00:00
Accession:  0001493152-22-033252
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.03, 5.03, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics announces 1-for-10 reverse stock split to regain Nasdaq compliance effective Nov 23
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio effective 12:01 a.m. ET on November 23, 2022; trading begins split-adjusted same day.
- Action taken to regain compliance with Nasdaq's $1.00 minimum bid price requirement; stockholders had approved ratio range up to 1-for-10.
- No fractional shares will be issued; cash payments made in lieu. All outstanding options, warrants, and equity plans adjusted proportionally.
- Equiniti Trust Company acts as exchange agent; new CUSIP number is 74754R 202; stock trades under same symbol QLGN.
- Board approved amendments to 2020 Stock Incentive Plan and 2022 ESPP to adjust share reserves for the reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315222033252/0001493152-22-033252-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315222033252/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-033252

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer